Kraig Biocraft Laboratories, Inc.
KBLB
$0.0871
$0.00364.31%
| Weiss Ratings | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.92 | |||
| Price History | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.22% | |||
| 30-Day Total Return | -0.46% | |||
| 60-Day Total Return | -8.32% | |||
| 90-Day Total Return | -3.22% | |||
| Year to Date Total Return | -10.21% | |||
| 1-Year Total Return | 1.16% | |||
| 2-Year Total Return | 100.23% | |||
| 3-Year Total Return | 10.96% | |||
| 5-Year Total Return | -64.82% | |||
| 52-Week High % Change | -46.97% | |||
| 52-Week Low % Change | 22.97% | |||
| Price | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.16 | |||
| 52-Week Low Price | $0.07 | |||
| 52-Week Low Price (Date) | Mar 07, 2025 | |||
| 52-Week High Price (Date) | Jun 24, 2024 | |||
| Valuation | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 87.06M | |||
| Enterprise Value | 93.33M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | 10.34% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -6.47 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.09 | |||
| Enterprise Value/EBITDA (TTM) | -30.62 | |||
| Enterprise Value/EBIT | -30.36 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.04B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 734 619 8066 | |||
| Address | 2723 South State Street Ann Arbor, MI 48104 | |||
| Website | www.kraiglabs.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -81.11% | |||
| Return on Equity | -- | |||
| Income Statement | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -3.05M | |||
| EBIT (TTM) | -3.07M | |||
| Net Income (TTM) | -3.40M | |||
| Net Income Avl. to Common (TTM) | -3.40M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 35.70% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 38.46% | |||
| Balance Sheet | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 673.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 740.30K | |||
| Total Preferred Equity (Q) | 5.24 | |||
| Total Equity (Q) | -8.15M | |||
| Current Ratio (Q) | 0.077 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 1.51M | |||
| Total Current Liabilities (Q) | 9.61M | |||
| Total Debt (Q) | 1.70M | |||
| Total Liabilities (Q) | 9.66M | |||
| Total Common Equity (Q) | -13.39M | |||
| Cash Flow | KBLB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -4.20K | |||
| Cash from Financing (TTM) | -35.20K | |||
| Net Change in Cash (TTM) | -1.88M | |||
| Levered Free Cash Flow (TTM) | -1.48M | |||
| Cash from Operations (TTM) | -1.84M | |||
